13D/13G Filings - Sio Gene Therapies Inc. (SIOX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-13
08:53 am
Sale		2022-12-3113GSio Gene Therapies Inc.
SIOX		SUVRETTA CAPITAL MANAGEMENT, LLC0
0.000%		-5,914,000decrease
(Position Closed)		Filing
History
2023-02-10
4:00 pm
Purchase		2022-12-3113GSio Gene Therapies Inc.
SIOX		Rubric Capital Management LP7,000,000
9.460%		7,000,000increase
(New Position)		Filing
History
2022-02-14
1:57 pm
Sale		2021-12-3113GSio Gene Therapies Inc.
SIOX		Consonance Capital Management LP0
0.000%		-6,058,505decrease
(Position Closed)		Filing
History
2022-02-11
4:45 pm
Purchase		2021-12-3113GSio Gene Therapies Inc.
SIOX		SUVRETTA CAPITAL MANAGEMENT, LLC5,914,000
8.100%		425,000increase
(+7.74%)		Filing
History
2021-02-26
4:24 pm
Purchase		2021-02-1713GSio Gene Therapies Inc.
SIOX		SUVRETTA CAPITAL MANAGEMENT, LLC5,489,000
8.600%		5,489,000increase
(New Position)		Filing
History
2021-02-16
4:27 pm
Unchanged		2020-12-3113GSio Gene Therapies Inc.
SIOX		Consonance Capital Management LP6,058,505
9.990%		0
(Unchanged)		Filing
History
2021-02-16
2:40 pm
Purchase		2020-12-3113GSio Gene Therapies Inc.
SIOX		Consonance Capital Management LP6,058,505
9.990%		6,058,505increase
(New Position)		Filing
History
2021-02-16
09:00 am
Unchanged		2020-12-3113GSio Gene Therapies Inc.
SIOX		Sphera Funds Management Ltd.0
0.000%		0
(Unchanged)		Filing
History